Brochure per i medici
- Brochure del prodotto BRACAnalysis
- Strumento BRACAnalysis per il medico (per la valutazione del rischio)
- Contralateral Breast Cancer in BRCA1 and BRCA2 mutation carriers. Metcalfe K, et al. J Clin Onc 2004; 22(12):2328-35.
- Association of risk-reducing surgery in BRCA1 and BRCA2 mutation carriers with cancer risk and mortalityDomchek SM, et al. JAMA 2010;304(9):967-75.
- The Risk of Ovarian Cancer after Breast Cancer in BRCA1 and BRCA2 carriers. Metcalfe K, et al. Gynecologic Oncology 2005; 96:222-226.
- Segregation analysis offers a mechanism for variant reclassification in a small subset of cases but is especially powerful in classifying deleterious mutations. Eggington J et al. Poster presented at the European Society of Human Genetics (ESHG) Congress 2013
- A clinical history weighting algorithm accurately classifies BRCA1and BRCA2 variants. Bowles K et al. Poster presented at the European Society of Human Genetics (ESHG) Congress 2013
- BRCA1/2 mutation prevalence among triple-negative breast cancer patients from a large commercial testing cohort. Poster presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013